CN113234014B - Aggregation-induced emission fluorescent probe for detecting aminopeptidase N and preparation thereof - Google Patents
Aggregation-induced emission fluorescent probe for detecting aminopeptidase N and preparation thereof Download PDFInfo
- Publication number
- CN113234014B CN113234014B CN202110452636.XA CN202110452636A CN113234014B CN 113234014 B CN113234014 B CN 113234014B CN 202110452636 A CN202110452636 A CN 202110452636A CN 113234014 B CN113234014 B CN 113234014B
- Authority
- CN
- China
- Prior art keywords
- compound
- solution
- dissolved
- probe
- aminopeptidase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102100022749 Aminopeptidase N Human genes 0.000 title claims abstract description 47
- QZDDFQLIQRYMBV-UHFFFAOYSA-N 2-[3-nitro-2-(2-nitrophenyl)-4-oxochromen-8-yl]acetic acid Chemical compound OC(=O)CC1=CC=CC(C(C=2[N+]([O-])=O)=O)=C1OC=2C1=CC=CC=C1[N+]([O-])=O QZDDFQLIQRYMBV-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 108010049990 CD13 Antigens Proteins 0.000 title claims abstract description 19
- 239000007850 fluorescent dye Substances 0.000 title claims abstract description 19
- 230000002776 aggregation Effects 0.000 title claims abstract description 18
- 238000004220 aggregation Methods 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000523 sample Substances 0.000 claims abstract description 39
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 30
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 18
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 229940125904 compound 1 Drugs 0.000 claims description 9
- 239000003208 petroleum Substances 0.000 claims description 9
- SMUQFGGVLNAIOZ-UHFFFAOYSA-N quinaldine Chemical compound C1=CC=CC2=NC(C)=CC=C21 SMUQFGGVLNAIOZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 claims description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 229940125782 compound 2 Drugs 0.000 claims description 8
- 229940126214 compound 3 Drugs 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 229940125898 compound 5 Drugs 0.000 claims description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- QVHJQCGUWFKTSE-YFKPBYRVSA-N (2s)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)OC(C)(C)C QVHJQCGUWFKTSE-YFKPBYRVSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- AXKGIPZJYUNAIW-UHFFFAOYSA-N (4-aminophenyl)methanol Chemical compound NC1=CC=C(CO)C=C1 AXKGIPZJYUNAIW-UHFFFAOYSA-N 0.000 claims description 4
- 239000007821 HATU Substances 0.000 claims description 4
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims description 4
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- 239000005457 ice water Substances 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 239000011541 reaction mixture Substances 0.000 claims description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- 229910020667 PBr3 Inorganic materials 0.000 claims 1
- 235000019441 ethanol Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 230000004044 response Effects 0.000 abstract description 6
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 230000008901 benefit Effects 0.000 abstract description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract description 4
- 238000010791 quenching Methods 0.000 abstract description 3
- 230000000171 quenching effect Effects 0.000 abstract description 3
- NTVVLLHKCZJVKS-UHFFFAOYSA-N 2-quinolin-2-ylpropanedinitrile Chemical compound C1=CC=CC2=NC(C(C#N)C#N)=CC=C21 NTVVLLHKCZJVKS-UHFFFAOYSA-N 0.000 abstract description 2
- 125000001980 alanyl group Chemical group 0.000 abstract description 2
- 101150058497 ANPEP gene Proteins 0.000 description 27
- 210000004027 cell Anatomy 0.000 description 20
- 239000000243 solution Substances 0.000 description 15
- 201000011510 cancer Diseases 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 239000011550 stock solution Substances 0.000 description 5
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 102000013392 Carboxylesterase Human genes 0.000 description 2
- 108010051152 Carboxylesterase Proteins 0.000 description 2
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 2
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 102000004459 Nitroreductase Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000799 fluorescence microscopy Methods 0.000 description 2
- 238000002189 fluorescence spectrum Methods 0.000 description 2
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 108020001162 nitroreductase Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 241000711573 Coronaviridae Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 108010004098 Leucyl aminopeptidase Proteins 0.000 description 1
- 102000002704 Leucyl aminopeptidase Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 1
- 101100016586 Natronomonas pharaonis hcy gene Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000001218 confocal laser scanning microscopy Methods 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1007—Non-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1003—Carbocyclic compounds
- C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
- C09K2211/10—Non-macromolecular compounds
- C09K2211/1018—Heterocyclic compounds
- C09K2211/1025—Heterocyclic compounds characterised by ligands
- C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
Abstract
The invention discloses a gathering induced emission fluorescent probe for detecting aminopeptidase N and a preparation method thereof, wherein the structure of a probe compound is shown as a formula I. The probe molecule consists of three main components: an aggregation-induced emission fluorophore based on quinoline-malononitrile, a self-cleavable linker and an aminopeptidase n (apn) -specific recognition group. When the N-terminal alanyl site of the probe compound is accurately hydrolyzed into amino by APN, the exposed amino is used as an electron supply group, so that the electron push-pull effect of a conjugated system is promoted, and the fluorescence is enhanced. The probe has the advantages of high response speed, high sensitivity, large Stokes shift and longer emission wavelength, and when the concentration of the solution is higher, the fluorescence emission is stronger, so that the problem of fluorescence quenching induced by aggregation is effectively solved.
Description
Technical Field
The invention relates to a position and expression level of active enzyme in a cell by a small molecular fluorescent probe in-situ detection, in particular to an accurate detection of endogenous aminopeptidase N content by the fluorescent probe based on aggregation-induced emission, belonging to the technical field of fluorescent probes.
Background
Aminopeptidase N (APN/CD 13), known as membrane-bound zinc ion-dependent type II metalloproteases, degrades neutral or basic amino acids at the N-terminus of the protein polypeptide chain. APN is accordingly involved in many important physiological and pathological processes in the body, such as signal transduction, immunomodulation, hydrolysis of bioactive peptides and invasion of coronaviruses. Many studies have shown that APNs are highly expressed on the surface of most tumor cells compared to normal cells, while APNs play a crucial role in the growth, invasion, metastasis and angiogenesis of malignant tumors. Therefore, APN has the potential to become a tumor cell biomarker, and the development of an effective method for tracking the activity of APN in vivo has great medical significance.
In recent years, the small molecule fluorescence imaging technology has attracted great interest, and the fluorescence imaging has obvious advantages in the aspects of rapid detection, high selectivity, high sensitivity, excellent time and spatial resolution, good biocompatibility and the like. To date, several fluorescent probes have been reported to monitor and visualize APNs in cells. However, most of the conventional fluorescent probes have hydrophobic characteristics of a planar structure. Such probes suffer from aggregation-induced fluorescence quenching problems (ACQ) in concentrated solutions or in aggregated states, which results in their emission being diminished or even quenched. In contrast to common ACQ dyes, Aggregation Induced Emission (AIE) fluorescent dyes have a rotatable structure or a twisted propeller-shaped conformation, which can produce high fluorescence emission due to the restriction of intramolecular movement. In particular, their fluorescence emission is stronger when the solution concentration is higher. Therefore, AIE fluorophores are ideal candidates for detecting APNs in organisms. In addition, probes with longer emission wavelengths (>600 nm) have less light damage and deeper tissue penetration, minimizing the unwanted effects of background fluorescence. However, to our knowledge, few aggregation-induced emission-based fluorescent probes that activate long-emission wavelength detection APN have been reported.
The invention discloses a gathering induced emission fluorescent probe for detecting aminopeptidase N and a preparation method thereof, wherein the structure of a probe compound is shown as a formula I. The probe molecule consists of three main components: an aggregation-induced emission fluorophore based on quinoline-malononitrile, a self-cleavable linker and an aminopeptidase n (apn) -specific recognition group. When the N-terminal alanyl site of the probe compound is accurately hydrolyzed into amino by APN, the exposed amino is used as an electron supply group, so that the electron push-pull effect of a conjugated system is promoted, and the fluorescence is enhanced. The probe has the advantages of high response speed, high sensitivity, large Stokes shift and longer emission wavelength, and when the concentration of the solution is higher, the fluorescence emission is stronger, so that the problem of fluorescence quenching induced by aggregation is effectively solved.
Disclosure of Invention
The technical problems to be solved by the invention are as follows: the probe compound has the advantage of carrying out aggregation-induced fluorescence in situ imaging on the endogenous APN of cancer cells and tissues. Secondly, a fluorescence diagnostic reagent is provided to effectively and accurately distinguish the liver cancer cells over expressing APN from normal cells. And thirdly, the fluorescent probe with high sensitivity and good selectivity is provided, and the defects of shallow tissue penetration depth and high background fluorescence of the probe can be overcome.
In order to solve the technical problems, the technical scheme is as follows:
the invention provides a gathering induced emission fluorescent probe for detecting aminopeptidase N, which has the following molecular structural formula:
compounds MQ-N
The invention also provides a preparation method of the aggregation-induced emission fluorescent probe for detecting aminopeptidase N, which comprises the following steps:
(1) (a) in N2Dissolving 2-methylquinoline (1 eq) and methyl iodide (2.5-3 eq) in acetonitrile under the atmosphere, refluxing the reaction solution for 10-15 hours, and concentrating under reduced pressure to obtain a compound 1; (b) dissolving compound 1 (1 eq) and malononitrile (2.5-3 eq) in absolute ethanol, continuously stirring at 0 ℃, adding sodium ethoxide, reacting for 5-8 hours, pouring the mixture into ice water, adjusting the pH (7.5-8.5), and filtering the generated precipitate to obtain compound 2; (c) compound 2 (1 eq) and p-hydroxybenzaldehyde (1.2-1.8 eq) were dissolved in acetonitrile, then piperazine was added to the solution, and the mixture was taken up in N2Refluxing for 8-12 h under atmosphere, and purifying with column (dichloromethane/petroleum ether) to obtain compound 3;
(2) (d) dissolving Boc-L-alanine (1 eq), HATU (1-1.2 eq) and DIPEA (2-3 eq) in an anhydrous dichloromethane solution at 0 ℃, stirring at room temperature for 0.5-1.5 hours, adding p-aminobenzyl alcohol (1-1.2 eq) to the reaction mixture, and further stirring at room temperature for 24-30 hours, column purification (dichloromethane/methanol) to obtain compound 4; (e) dissolving compound 4 (1 eq) in anhydrous tetrahydrofuran andadding PBr at 0 DEG C3(1.2-1.6 eq), stirring the mixture for 2-5 hours, and column purification (petroleum ether/ethyl acetate) to give compound 5;
(3) (f) dissolving Compound 3 (1 eq) and Compound 5 (1.1-1.2 eq) in anhydrous DMF solution, and adding K2CO3And stirred at 120 ℃ for 6-8 hours, column purified (petroleum ether/ethyl acetate) to give the compound MQ-N.
The invention has the advantages that:
the fluorescent probe molecule has the property of aggregation-induced fluorescence emission, can effectively reduce the interference of background fluorescence on detection signals, and improves the tissue penetration depth in vivo imaging.
The fluorescent probe molecule has very high response speed to aminopeptidase N, can completely respond within 20 minutes, and can be applied to quickly detecting the enzyme content in a complex sample.
The fluorescent probe molecule has good sensitivity and selectivity, a fluorescent signal only occurs in the presence of aminopeptidase N, and other common inorganic salts, amino acids, biological enzymes and the like cannot cause the probe solution to generate the change of a fluorescence spectrum.
Therefore, the invention provides a reliable means for non-invasively monitoring the change of the activity of leucine aminopeptidase in vivo. Has wide application prospect in the field of biological analysis and detection.
Detailed Description
The present invention will be described in further detail with reference to specific examples.
Example 1
A preparation method of an aggregation-induced emission fluorescent probe for detecting aminopeptidase N comprises the following steps:
1) synthesis of Compound 1:
in N22-methylquinoline (1.79 g, 12.5 mmol) and iodomethane (5.50 g, 35 mmol) were dissolved in acetonitrile (25 mL) under an atmosphere, and the reaction was refluxed for 10 hours and the solvent was evaporated under reduced pressure to give compound 1 in 75% yield.
Synthesis of Compound 2:
compound 1 (1.74 g, 6 mmol) and malononitrile (1.20 g, 18 mmol) were dissolved in absolute ethanol (15 mL) and stirred constantly at 0 ℃, reacted for 6 hours after addition of sodium ethoxide, the mixture was poured into ice water, after adjusting the pH to 8, the resulting precipitate was filtered, washed with water and dried in vacuo to give compound 2 in 85% yield.
Synthesis of Compound 3:
compound 2 (1.40 g, 7.5 mmol) and p-hydroxybenzaldehyde (1.65 g, 13.5 mmol) were dissolved in acetonitrile (30 mL), then piperazine was added to the solution, and the mixture was stirred in N2Reflux under atmosphere for 12 h, evaporation of solvent under reduced pressure, and column purification (dichloromethane/petroleum ether = 2/1) afforded compound 3 in 65% yield.
2) Synthesis of Compound 4:
Boc-L-alanine (0.17 g, 0.9 mmol), HATU (0.42 g, 1.1 mmol) and DIPEA (0.37 mL, 2.3 mmol) were dissolved in anhydrous dichloromethane solution (30 mL) at 0 ℃, stirred at room temperature for 1.2 hours, p-aminobenzyl alcohol (0.14 g, 1.1 mmol) was added to the reaction mixture and further stirred at room temperature for 25 hours, the solvent was evaporated under reduced pressure and column purified (dichloromethane/methanol = 20/1) to give compound 4 in 70% yield.
Synthesis of Compound 5:
(e) compound 4 (0.59 g, 2 mmol) was dissolved in anhydrous tetrahydrofuran (10 mL) and PBr was added at 0 deg.C3(0.23 mL, 2.4 mmol), the mixture was stirred for 3 hours, the solvent was evaporated under reduced pressure and column purified (petroleum ether/ethyl acetate = 9/1) to give compound 5 in 40% yield.
3) Synthesis of Compound MQ-N:
compound 3 (0.37 g, 1.1 mmol) and compound 5 (0.43 g, 1.2 mmol) were dissolved in anhydrous DMF solution (5 mL) and K was added2CO3And stirred at 120 ℃ for 7 hours, the solvent was evaporated under reduced pressure and column purified (petroleum ether/ethyl acetate = 10/1) to give compound MQ-N in 65% yield.
Example 2
Measurement of MQ-N absorption and fluorescence spectra of probes
A stock solution (1.0 mM) of the probe MQ-N in DMSO was prepared in a test tube using the MQ-N synthesized in example 1. Preparation of NaCl, KCl, CaCl in distilled water2,ZnCl2,MgCl2,CuCl2,H2O2Stock solutions of NaClO, glucose, GSH, Cys, Hcy, alkaline phosphatase, gamma-glutamyltranspeptidase, nitroreductase, carboxylesterase, and the like. The final volume of each stock was adjusted to 5 mL with phosphate buffer. For spectroscopic experiments, after incubating the MQ-N stock solution with a quantity of analyte in a quartz cuvette for 30 minutes at pH =7.4, 3 mL of the reaction solution was transferred to a 1 cm quartz cuvette with excitation set to 480 nm and emission wavelength 500 and 700 nm. Meanwhile, a control group without aminopeptidase N was prepared and compared under the same conditions. MQ-N shows double absorption peaks near 350 nm and 425 nm, and after APN is added to the micelle probe, the absorption peak centered at 350 nm is weakened, and then the peak at 425 nm is remarkably increased. The characteristics of the probe MQ-N under APN treatment at different concentrations were then evaluated, with increasing APN the fluorescence intensity gradually increasing at 630 nm. Experimental data show that MQ-N has quite high sensitivity to APN and can quantitatively detect APN concentration.
Example 3
Evaluating the influence of different pH values and temperatures on the MQ-N fluorescence of the probe
Taking MQ-N stock solution (10. mu.M) from example 2, the probe was almost non-fluorescent in the pH range of 4.0-8.0 and the temperature range of 23-40 ℃, indicating a high stability of the probe. After reaction with aminopeptidase N, the probe produced a significant fluorescent response throughout the pH range tested, although the maximum fluorescence intensity occurred in the pH range of 6.0-7.4. On the other hand, the strongest fluorescence of the reaction solution occurs at about 37 ℃, which is consistent with the fact that enzymes typically have the greatest activity at 37 ℃. The result shows that the probe MQ-N has good function under normal physiological conditions.
Example 4
Specific detection of APN by probe MQ-N
Taking MQ-N stock solution (10. mu.M) from example 2, the fluorescent response of the probe to APN and some potential interferents, such as some metal ions (Na) that may form complexes with the probe or APN, were tested+,K+,Ca2+,Zn2+,Mg2+And Cu2 +) Possibly oxidizing the active oxygen (NO) of the probe2 -,NO,HNO,1O2,H2O2,ClO-TBHP,. OH and O2 -) Biomolecules (GSH, Hcy and Cys) and APN-related enzymes (alkaline phosphatase, gamma-glutamyltranspeptidase, nitroreductase, carboxylesterase, beta-galactosidase, etc.). When APN was added to the MQ-N solution, the fluorescence intensity at 630 nm increased significantly, but the other substances failed to cause significant fluorescence change. Subsequent further competitive experiments with APN and other interfering substances were performed, and the results indicated that the APN-induced fluorescence response was not affected by other interferences. Therefore, probe MQ-N has superior selectivity for APN in various competitive analytes.
Example 5
Toxicity of MQ-N to cancer cells and determination of endogenous APN
Cell viability was tested by a method of reducing MTT using mitochondrial dehydrogenase. HepG-2 cells at 1X 105cells/mL were seeded in 96-well microplates containing LBS in medium. After 24 hours of cell attachment, the plates were then washed with PBS and the cells were cultured in media containing 0, 1, 2, 5, and 10 μ M probe MQ-N for 24 hours. Meanwhile, cells not cultured with the probe MQ-N were set up as a control. MTT (10. mu.L, 5 mg/mL) was injected into each well and the plates were incubated in 5% CO2Incubate in a humidified incubator for 4 hours. Then removing the culture medium and using the enzymeThe optical density of the solution was measured at 490 nm with a standard instrument to assess cell viability. After 24 hours of treatment of the cells with different concentrations of MQ-N, more than 90% of the cells survived, demonstrating low toxicity of the probe to the cells. Subsequently, MQ-N was evaluated by confocal fluorescence microscopy for the ability to track endogenous APNs in cancer and normal cells. 5% CO at MQ-N (5. mu.M) and 37 ℃2The cells were pretreated for 0.5 hour, and there was almost no fluorescence in normal cells. In contrast, the red fluorescence signal increased dramatically after probe incubation with cancer cells. Therefore, these data indicate that the probe MQ-N exhibits good membrane permeability and can effectively distinguish between cancer cells and normal cells.
The foregoing is only a preferred embodiment of this invention and is not intended to limit the invention in any way, so that any person skilled in the art may, using the teachings disclosed above, modify or adapt for various equivalent embodiments with equivalent modifications. The design concept of the present invention is not limited thereto, and any insubstantial modifications made to the present invention using this concept shall fall within the scope of infringing upon the present invention.
Claims (4)
1. A preparation method of an aggregation-induced emission fluorescent probe for detecting aminopeptidase N is characterized in that the structure of the compound is shown as a formula I:
formula I;
the preparation method comprises the following steps:
(1) (a) in N2Dissolving 2-methylquinoline and methyl iodide in acetonitrile under the atmosphere, refluxing the reaction solution for 10-15 hours, and concentrating under reduced pressure to obtain a compound 1; (b) dissolving the compound 1 and malononitrile in absolute ethyl alcohol, continuously stirring at 0 ℃, adding sodium ethoxide, reacting for 5-8 hours, pouring the mixture into ice water, adjusting the pH, and filtering the generated precipitate to obtain a compound 2; (c) dissolving Compound 2 and p-hydroxybenzaldehyde in acetonitrile, and adding piperazineTo this solution, the mixture is dissolved in N2Refluxing for 8-12 hours under the atmosphere, and purifying by a column to obtain a compound 3;
(2) (d) dissolving Boc-L-alanine, HATU and DIPEA in an anhydrous dichloromethane solution at 0 ℃, stirring at room temperature for 0.5-1.5 hours, adding p-aminobenzyl alcohol to the reaction mixture, further stirring at room temperature for 24-30 hours, and column purifying to obtain compound 4; (e) compound 4 was dissolved in anhydrous tetrahydrofuran and PBr was added at 0 deg.C3Stirring the mixture for 2-5 hours, and purifying the mixture by a column to obtain a compound 5;
(3) (f) dissolving Compound 3 and Compound 5 in anhydrous DMF, and adding K2CO3Stirring at 120 deg.C for 6-8 hr, and purifying with column to obtain compound MQ-N
2. The method for preparing the fluorescence probe for detecting aggregation-induced emission of aminopeptidase N according to claim 1, wherein the fluorescence probe comprises: the molar ratio of the 2-methylquinoline to the methyl iodide in the step (1) (a) is in the range of 1: (2.5-3); the molar concentration range of the 2-methylquinoline dissolved in the acetonitrile solution is 0.35-0.55 mol.L-1(ii) a (b) The molar ratio of the compound 1 to the malononitrile is 1: (2.5-3); the molar concentration range of the compound 1 dissolved in the ethanol solution is 0.3-0.45 mol.L-1(ii) a Adjusting the pH range to 7.5-8.5; (c) the mol ratio of the compound 2 to the p-hydroxybenzaldehyde is 1: (1.2-1.8); the molar concentration range of the compound 2 dissolved in the acetonitrile solution is 0.2-0.35 mol.L-1(ii) a Column purityThe volume ratio of dichloromethane to petroleum ether in the reaction is (2-1): 1.
3. the method for preparing the fluorescence probe for detecting aggregation-induced emission of aminopeptidase N according to claim 1, wherein the fluorescence probe comprises: in the step (2) (d), the mole ratio of Boc-L-alanine, p-aminobenzyl alcohol, HATU and DIPEA is in the range of 1: (1-1.2): (1-1.2): (2-3); the molar concentration range of the Boc-L-alanine dissolved in the anhydrous dichloromethane solution is 0.025-0.035 mol.L-1(ii) a The volume ratio of the dichloromethane to the methanol in the column purification is (20-15): 1; (e) compound 4 and PBr3The molar ratio ranges from 1: (1.2-1.6); the molar concentration range of the compound 4 dissolved in the anhydrous tetrahydrofuran solution is 0.2-0.26 mol.L-1(ii) a The volume ratio of petroleum ether to ethyl acetate in column purification is (10-5): 1.
4. the method for preparing the fluorescence probe for detecting aggregation-induced emission of aminopeptidase N according to claim 1, wherein the fluorescence probe comprises: the molar ratio of the compound 3 to the compound 5 in the step (3) (f) is in the range of 1: (1.1-1.2); the molar concentration of the compound 3 dissolved in the anhydrous DMF solution is 0.2-0.24 mol.L-1(ii) a The volume ratio of petroleum ether to ethyl acetate in column purification is (10-6): 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110452636.XA CN113234014B (en) | 2021-04-26 | 2021-04-26 | Aggregation-induced emission fluorescent probe for detecting aminopeptidase N and preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110452636.XA CN113234014B (en) | 2021-04-26 | 2021-04-26 | Aggregation-induced emission fluorescent probe for detecting aminopeptidase N and preparation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113234014A CN113234014A (en) | 2021-08-10 |
CN113234014B true CN113234014B (en) | 2022-04-26 |
Family
ID=77129241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110452636.XA Active CN113234014B (en) | 2021-04-26 | 2021-04-26 | Aggregation-induced emission fluorescent probe for detecting aminopeptidase N and preparation thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113234014B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115109079B (en) * | 2022-06-21 | 2023-07-04 | 南京工业大学 | Polyurethane degrading enzyme specific fluorescent probe, preparation method and application thereof |
CN116987131A (en) * | 2022-12-08 | 2023-11-03 | 中国科学院昆明动物研究所 | Near infrared biological probe for targeting aging cells and preparation method and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107011324A (en) * | 2016-01-28 | 2017-08-04 | 中国科学院大连化学物理研究所 | DPP IV enzyme near infrared fluorescent probe substrate and preparation method and application |
CN110330505B (en) * | 2019-07-30 | 2021-07-09 | 济南大学 | Two-photon ratio type fluorescent probe compound for aminopeptidase N detection and preparation method thereof |
-
2021
- 2021-04-26 CN CN202110452636.XA patent/CN113234014B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113234014A (en) | 2021-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113234014B (en) | Aggregation-induced emission fluorescent probe for detecting aminopeptidase N and preparation thereof | |
CN110283583B (en) | Gamma-glutamyl transpeptidase responsive molecular probe and application thereof | |
CN106749034B (en) | Ratio-type fluorescent labeling reagent and its synthetic method and application are answered to bisulfite and hypochlorite double-bang firecracker | |
Liu et al. | Development of a mitochondria targetable ratiometric time-gated luminescence probe for biothiols based on lanthanide complexes | |
Han et al. | Rational design of a lysosomal-targeted ratiometric two-photon fluorescent probe for imaging hydrogen polysulfides in live cells | |
US8968997B2 (en) | Benzoxazole-based fluorescent metal ion indicators | |
CN1715919A (en) | Fluoroboric dye fluorescent probe for cell zinc ion detection | |
CN112794857B (en) | Fluorescent probe for ferrous ion detection and preparation and application thereof | |
CN113061109B (en) | Morpholine-pyridine-merocyanine derivative fluorescent probe and preparation method and application thereof | |
CN113637048B (en) | Two-photon fluorescent probe of gamma-glutamyl transpeptidase and preparation method and application thereof | |
CN110330505B (en) | Two-photon ratio type fluorescent probe compound for aminopeptidase N detection and preparation method thereof | |
CN114195839A (en) | Lysosome targeted fluorescent probe for glucuronidase detection and preparation thereof | |
CN111635385B (en) | Mitochondrion-targeted two-photon excitation near-infrared emission hydrogen sulfide fluorescent probe and preparation method and application thereof | |
CN109369565A (en) | A kind of benzothiazole derivant and its preparation method and application | |
Li et al. | A novel dual-capability naphthalimide-based fluorescent probe for Fe 3+ ion detection and lysosomal tracking in living cells | |
CN114516850A (en) | Fluorescent probe for detecting tyrosinase as well as preparation method and application thereof | |
CN113025313A (en) | Application of morpholine-pyridine-part cyanine derivative as hydrogen sulfide fluorescent probe | |
CN112694469A (en) | HOCl fluorescent probe based on pyrrazone and red hydrazine, preparation method and application | |
CN115745991B (en) | Detection SO of targeting lysosome 2 Derivative or viscosity ratio fluorescent probe and application thereof | |
KR102089393B1 (en) | Fluorescent probe for detecting NAD(P)H in mitochondria, and method for detecting using the same | |
CN116462639B (en) | Fluorescent probe for specifically recognizing alanine aminopeptidase as well as preparation method and application thereof | |
CN114507204B (en) | Golgi apparatus targeted superoxide anion fluorescent probe, preparation method and application thereof | |
CN113173952B (en) | Ortho-dithiol reactive therapeutic probe for drug release monitoring and preparation | |
CN115873011B (en) | Cancer cell targeted fluorescent probe responding to nitroreductase in mitochondria and preparation method and application thereof | |
KR102598150B1 (en) | Novel phenylalanine derivative compound and use for detecting copper(Cu2+) ion thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |